Related Experiment Video
Updated: Jun 5, 2026

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System
Published on: May 5, 2018
Cardiogenetic screening of first-degree relatives after sudden cardiac death in the young: a population-based
Anneke Hendrix1, C Jan Willem Borleffs, Aryan Vink
1Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands. a.hendrix@umcutrecht.nl
Insights
Cardiogenetic screening of relatives of sudden cardiac death (SCD) and sudden unexplained death (SUD) victims yielded a 14% diagnosis rate for inherited heart conditions. This highlights a need for systematic screening approaches in population-based settings.
Area of Science:
- Cardiology
- Genetics
- Public Health
Background:
- Sudden cardiac death (SCD) and sudden unexplained death (SUD) in young individuals often have genetic underpinnings.
- Family screening is crucial for identifying inherited cardiac conditions and preventing future events.
- Current population-based screening practices for relatives of SCD/SUD victims may be suboptimal.
Purpose of the Study:
- To evaluate the diagnostic yield of cardiogenetic screening in first-degree relatives of young SCD/SUD victims.
- To assess the effectiveness of a population-based approach to family screening after sudden cardiac events.
Main Methods:
- A population-based study reviewed SCD/SUD cases (ages 1-40) from 2000-2006.
- Autopsy and cardiogenetic screening data for victims and their first-degree relatives were collected.
- Relatives without prior screening were invited for additional cardiogenetic evaluation.
Main Results:
- The study identified 16 SCD/SUD cases and 4 aborted SCD/SUD cases.
- Common causes included myocardial infarction, arrhythmogenic right ventricular cardiomyopathy (ARVC), and hypertrophic cardiomyopathy.
- Screening 37 relatives of 12 victims identified Brugada syndrome in 3 and suspected ARVC in 2, yielding a 14% detection rate.
Conclusions:
- A significant proportion of relatives of SCD/SUD victims are not referred for cardiogenetic screening.
- Systematic screening approaches are needed to improve the detection of inherited cardiac diseases.
- The yield of cardiogenetic screening in this population, while substantial, was lower than anticipated.
Aims:
To investigate the yield of cardiogenetic screening of relatives of young sudden cardiac death (SCD) and sudden unexplained death (SUD) victims in a population-based setting.
Methods And Results:
A population-based study was carried out between 2000 and 2006. Records of the hospital, death declaration certificates, and resuscitation records were reviewed for SCD and SUD cases (1-40 years). Information on autopsy results and cardiogenetic screening of the victims' first-degree relatives was collected. Relatives were invited for additional cardiogenetic screening when this had not yet been performed. The search led to 16 cases of SCD/SUD and 4 cases of aborted SCD/SUD. Causes of SCD/SUD were myocardial infarction (n = 3), arrhythmogenic right ventricular cardiomyopathy (ARVC) (n = 2), long-QT syndrome (n = 1), hypertrophic cardiomyopathy (n = 2), left ventricular hypertrophy due to aortic stenosis (n = 1), and unknown cause of death (n = 7). Causes of aborted SCD/SUD were myocardial infarction (n = 2), idiopatic ventricular fibrillation (n = 1), and the Brugada syndrome (n = 1). The cardiogenetic screening of 37 relatives of 12 victims led to a diagnosis of Brugada syndrome in 3 relatives and the suspicion of ARVC in 2 relatives. The yield of screening of these relatives was 14% (95% confidence interval: 3-25%).
Conclusion:
In the usual care, relatives of (aborted) SCD and SUD victims are often not referred for cardiogenetic screening. Screening is often not performed according to a systematic approach, and the detection rate of inherited diseases in relatives of (aborted) SCD and SUD victims in a population-based setting, although substantial, is lower than expected based on previous studies.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Coronary Artery Disease IV: Preventive Measures
Cardiomyopathy II: Dilated Cardiomyopathy
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Introduction Cardiac Emergencies

